Market Tracker

04/01 6:02pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

During the Trading Day
77.45 +0.34 / +0.44%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
77.45 0.00 / 0.00%
 
Volume: 10.4K

Today’s Trading

Previous close77.11
Today’s open77.63
Day’s range75.76 - 78.84
Volume630,736
Average volume (3 months)347,219
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+42.60%
Earnings growth (next 5 years)+38.40%
Revenue growth (last year)+31.78%
P/E ratio138.3
Price/Sales16.83
Price/Book57.35

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc-0.37-0.98%
NLNKNewLink Genetics Cor...-0.77-1.41%
ACORAcorda Therapeutics ...+0.29+0.87%
USNAUSANA Health Science...+2.07+1.86%
Data as of 4:02pm ET, 04/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.27
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President, Chief Operating Officer &
Director
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts